GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Common Stock

BNR (Burning Rock Biotech) Common Stock : $0.02 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Common Stock?

Burning Rock Biotech's quarterly common stock increased from Jun. 2024 ($0.02 Mil) to Sep. 2024 ($0.02 Mil) but then stayed the same from Sep. 2024 ($0.02 Mil) to Dec. 2024 ($0.02 Mil).

Burning Rock Biotech's annual common stock declined from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.02 Mil) but then increased from Dec. 2023 ($0.02 Mil) to Dec. 2024 ($0.02 Mil).

Burning Rock Biotech Common Stock Historical Data

The historical data trend for Burning Rock Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Common Stock Chart

Burning Rock Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial 0.02 0.02 0.02 0.02 0.02

Burning Rock Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

Burning Rock Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Burning Rock Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Common Stock
Comparable Companies
OCX PRE ME XGN MDXH BIOQ FONR ENZ BDSX PRPH TMO DHR XSWX:LONN A IDXX IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
6BU0:Germany
Address
No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005
Website
https://www.brbiotech.com
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.